April 7 coronavirus news

While vaccine requirements won’t come from federal government mandates, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he would be very surprised if there weren’t local level requirements. 

“I don’t think I could come out and officially say I support it because that’s going to be taken, I think, out of context in some cases,” Fauci said, asked by CBS’s Tony Dokoupil if, from a public health perspective, he supported vaccine requirements for businesses and organizations.

Fauci made clear that, “You’re not going to see that from a federal government mandate,” but said he would be "surprised if we did not see that at the local level.” 

A White House official says that by the end of this weekend, the US will be approaching having nearly half of all adults with their first shot of the coronavirus vaccine.

That clarification comes after President Biden's coronavirus adviser Andy Slavitt gave an ambitious timeline to CNN's Chris Cuomo on Tuesday night.

"We're on track that by the weekend, half the adults in the country will have had their first shot,” Slavitt said.

The Centers for Disease Control and Prevention says 41.7% of the population over 18 has received at least one dose of vaccine.

The wealthy German state of Bavaria is set to buy 2.5 million doses of Russia’s Sputnik vaccine, as soon as it is approved by the European Union’s drug regulator, the state’s prime minister said on Wednesday. 

Illertissen is a vaccine producer based in Bavaria. The decision is in anticipation of a predicted shortfall in vaccine supplies expected in the coming months. 

The United States doesn’t need AstraZeneca’s Covid-19 vaccine doses, Dr. Anthony Fauci told CNN Wednesday. 

Several European countries have paused their AstraZeneca vaccine distribution amid concerns that the vaccine might be linked to rare types of blood clots, or made rules that only people over a certain of age can receive it. No link has been established between the vaccine and blood clots.

At a congressional hearing on March 22, Ruud Dobber, president of AstraZeneca's biopharmaceuticals business unit, said the company was “expecting” to have an EUA “at the beginning of April.” However, in media interviews he said the company was expecting to apply for an EUA in the first half of April.

Fauci said if AstraZeneca applies to the US Food and Drug Administration, they might receive an EUA, but that the doses weren’t needed in the US.

Last month, Emer Cooke, executive director of the European Medicines Agency, said the agency had come to a conclusion that the AstraZeneca vaccine "a is a safe and effective vaccine."

Cooke said the group did not find that the vaccine causes clotting, though it could not definitively rule out a link to a rare blood clotting disorder. Cooke added that the benefits of AstraZeneca’s vaccine outweigh the risks, a message already stressed by both the EMA and World Health Organization.

Half of the adults in the US should have received at least one Covid-19 vaccine dose by this weekend, White House senior adviser for Covid-19 response Andy Slavitt said Tuesday.

Slavitt did not fully explain his calculation, but indicated he expected the pace of vaccinations will pick up.  The Centers for Disease Control and Prevention says 41.7% of the population over 18 has received at least one dose of vaccine.

“It's getting easier,” Slavitt said. “Part of it's because there's more supply. Part of it is because it's in more places. Part of it is because there's more vaccinators,” he added.

But this does not mean the country is finished with the pandemic, the White House adviser note.

President Biden said Tuesday that every adult in the US should be eligible for a vaccine on April 19, up from the original May 1 deadline.

“We've got about 76% of seniors that have had their first shot,” Slavitt said. “Now what's going to happen in the next couple of weeks, is we really need to make sure that more seniors get their shots, because starting on the 19th, we're going to have some more floodgates again,” he said. “We're going to have more people coming.”

Slavitt said that the US needs to keep pushing on Covid-19 vaccinations, so everyone who wants a shot can get one.

“We think that's going to happen as we get into May – as we get towards the end of May,” he said.

From CNN's Madeline Holcombe contributed reporting to this post. 

Hungary begins to ease anti-coronavirus restrictions on Wednesday, just as the country has vaccinated 2.5 million people and despite battling a third wave of Covid-19 infections.

Starting on Wednesday morning, the country's shops opening times are being extended from 7 p.m. to 9.30 p.m. local time, with capacity reduced to one costumer per 10 square meters.

Night-time curfew restrictions are relaxed from 8 p.m. to 10 p.m. local time, with hair and beauty businesses also allowed to reopen. Bars and restaurants must remain closed and hotels cannot yet welcome guests.

On Tuesday, Prime Minister Viktor Orbán called the vaccination number "an important milestone.”

“The virus waged a war against us, and the only weapon that promises victory is the vaccine,” Orbán said. ���Hungary can be and will be the country where everyone gets a vaccine the fastest.”

Last week, the Prime Minister also signaled that on April 19, kindergartens, and primary and secondary schools will would reopen as well. He told public broadcaster, Kossuth Rádió, the next step will be taken when the vaccinated number reaches 3-3.5 million, adding that he would provide further details this Friday.

Why it matters: Hungary, with a population just under 10 million, has been in lockdown for a month as it struggled to bring down infection rates.

Last week, the country recorded its deadliest day of the pandemic so far with 302 people dying from the virus in a single day.

This Tuesday, health authorities reported at least 1,890 new cases, bringing the total to 691,743, for 170 additional deaths.

There are currently 12,007 people hospitalized with Covid-19, 1,440 of whom are on ventilators, with 251,077 coronavirus cases currently active in the country.

India's Maharashtra state, where the country's highest new daily coronavirus cases are being reported, has asked the central government to increase vaccine supply amid a shortage, the state's minister of health said.

Tope said he has requested the central Indian authorities to supply more doses of the Covaxin and Covishield vaccines. "In both cities and villages, we have created teams… to bring all those above 45 years old to take the vaccine," he added. "We have had a fast mobilization of recipients but haven’t received enough vaccines."

On Tuesday, Maharashtra state recorded 55,469 new cases, nearly half the new cases across the whole country, according to the state health department. Mumbai, the state capital, recorded 10,030 new cases on Tuesday, according to the city administration.

Kishori Pednekar, the mayor of Mumbai, said the shortage comes at a time when there is rising trust in Covid-19 vaccines. "People want to take the vaccine quickly," she told local media. "We are facing shortages of both Covishield and Covaxin, till yesterday we had only 176000 doses of Covaxin left, at this rate it will become difficult to provide even the second dose of the vaccine to those who have already received the first."

Maharashtra has administered the highest number of vaccine doses of any state, with 8,127,248 people receiving the first dose of the vaccine, the Indian Ministry of Health said on Tuesday.

Second wave grips the country: India on Wednesday reported over 115,000 new cases of coronavirus, the highest single-day total since the pandemic began, according to a CNN tally of figures from the Indian Ministry of Health. The country has seen a rapid surge in Covid-19 cases since March.

Several Indian cities and states have reinstated coronavirus restrictions in the second wave. Maharashtra has imposed weekend lockdowns and curfews, the union territory of Delhi has ordered a night curfew, and in the western state of Gujarat, a night curfew has been implemented in 20 cities.

South Korea will temporarily suspend use of the AstraZeneca Covid-19 vaccine for people under 60 and nursing teachers, the Korea Disease Control and Prevention Agency (KDCA) said in a press release on Wednesday. 

The KDCA said the decision was made because the European Medicines Agency (EMA) is currently reviewing the link between the AstraZeneca vaccine and instances of rare blood clots reported among some patients. 

Nursing teachers were scheduled to receive the AstraZeneca vaccine starting Thurs, but the plan has been postponed. 

KDCA Commissioner Jeong Eun-kyeong said the decision is a “preemptive action” as they consider people’s safety as the top priority. She added that they will have an in-depth discussion with local experts following an investigation by the EMA, before announcing further actions in a prompt manner.

Earlier Wednesday, South Korea granted conditional approval use for Johnson & Johnson’s Janssen coronavirus vaccine, the country's Food and Drug Safety Ministry said.

The moves come as a senior health official warned of the increasing possibility the nation was heading into a fourth Covid-19 wave. South Korea reported 668 new cases from Tuesday, the biggest daily jump since January 8.

The EMA's Pharmacovigilance Risk Assessment Committee is expected to hold a virtual press briefing Wednesday at 10 a.m. ET following its latest review of AstraZeneca and thromboembolic events.

The German government is calling for a short country-wide lockdown to try and curb the spread of Covid-19. 

“Every call for a short, unified, lockdown is correct,” Ulrike Demmer, the spokeswoman for German Chancellor Angela Merkel, confirmed on Wednesday.

“The variety of the current measures are not contributing to safety or to acceptance,” she added, highlighting the importance of a "common federal approach." 

Demmer went on to say the current situation was unsustainable, with too much pressure on German healthcare. “We need a stable incidence rate below 100,” she concluded.

Last week, Germany's public health authority, the Robert Koch Institute, found that the coronavirus variant B.1.1.7 -- which was first identified in the UK -- accounted for nearly 90% of new infections in the country.